I agree that this site is using cookies. You can find further informations here.
X
Curti, Brendan D
142  results:
Search for persons X
?
1

Baseline biomarkers of efficacy and on-treatment immune-pro..:

Gogas, Helen ; Ravimohan, Shruthi ; Datta, Antara...
npj Precision Oncology.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

A phase 1 study of triple‐targeted therapy with BRAF, MEK, ..:

Algazi, Alain P. ; Moon, James ; Lao, Christopher D....
Cancer.  130 (2024)  10 - p. 1784-1796 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Phase 1/2 study of PRO1160, a CD70-directed antibody-drug c..:

Jonasch, Eric ; Call, Justin ; Kambhampati, Swetha...
The Oncologist.  28 (2023)  Supplement_1 - p. S14-S15 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Regulation of human and mouse bystander T cell activation r..:

Le, Catherine T. ; Vick, Logan V. ; Collins, Craig...
JCI Insight.  8 (2023)  18 - p. , 2023
Link: https://doi.org/10.1172/..
 
?
5

Cancer's Dark Matter: Lighting the Abyss Unveils Universe o..:

Fox, Bernard A. ; Urba, Walter J. ; Jensen, Shawn M....
Clinical Cancer Research.  29 (2023)  12 - p. 2173-2175 , 2023
Link: https://doi.org/10.1158/..
 
?
6

Phase 1, open-label, dose-escalation study on the safety, p..:

Rudin, Charles M ; Pandha, Hardev S ; Zibelman, Matthew...
Journal for ImmunoTherapy of Cancer.  11 (2023)  1 - p. e005007 , 2023
Link: https://doi.org/10.1136/..
 
?
7

A phase Ib study of interleukin-2 plus pembrolizumab for pa..:

Silk, Ann W. ; Curti, Brendan ; Bryan, Jennifer...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

Phase 1 dose-escalation study of SEA-CD40: a non-fucosylate..:

Coveler, Andrew L ; Smith, David C ; Phillips, Tycel...
Journal for ImmunoTherapy of Cancer.  11 (2023)  6 - p. e005584 , 2023
Link: https://doi.org/10.1136/..
 
?
9

A Phase II, Single-arm Trial of Sunitinib and Erlotinib in ..:

Feng, Zizhen ; Curti, Brendan D. ; Quinn, David I....
Clinical Genitourinary Cancer.  20 (2022)  5 - p. 415-422 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Intratumoral oncolytic virus V937 plus ipilimumab in patien..:

Curti, Brendan D ; Richards, Jon ; Hyngstrom, John R...
Journal for ImmunoTherapy of Cancer.  10 (2022)  12 - p. e005224 , 2022
Link: https://doi.org/10.1136/..
 
?
11

Patient-reported tolerability of adjuvant ipilimumab (3 or ..:

McLouth, Laurie E. ; Zheng, Yue ; Smith, Stephanie...
Quality of Life Research.  32 (2022)  1 - p. 183-196 , 2022
Link: https://doi.org/10.1007/..
 
?
12

A Random Forest Genomic Classifier for Tumor Agnostic Predi..:

Bigelow, Emma ; Saria, Suchi ; Piening, Brian...
Cancer Informatics.  21 (2022)  - p. 117693512211360 , 2022
Link: https://doi.org/10.1177/..
 
?
13

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with h..:

Duhen, Rebekka ; Ballesteros-Merino, Carmen ; Frye, Alexandra K....
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
14

HDAC inhibition prevents transgene expression downregulatio..:

Moore, Tamson V. ; Scurti, Gina M. ; DeJong, Matthew...
Molecular Therapy - Oncolytics.  20 (2021)  - p. 352-363 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Long-Term Progression-Free Survival of Patients with Metast..:

Clark, Joseph I ; Curti, Brendan ; Davis, Elizabeth J...
Journal of Investigative Medicine.  69 (2021)  4 - p. 888-892 , 2021
Link: https://doi.org/10.1136/..
 
1-15